Therapeutic improvement of CFTR function and reversibility of bronchiectasis in cystic fibrosis
The study by Cazier and co-workers promotes current efforts to diagnose and treat CF lung disease as early as possible in order to prevent structural lung damage, and to target initially reversible changes before persistent airway damage is established
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
14 Feb 2024
|
| In: |
The European respiratory journal
Year: 2024, Jahrgang: 63, Heft: 3, Pages: 2400234-1-2400234-6 |
| ISSN: | 1399-3003 |
| DOI: | 10.1183/13993003.00234-2024 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1183/13993003.00234-2024 Verlag, lizenzpflichtig, Volltext: https://erj.ersjournals.com/content/63/3/2400234 
|
| Verfasserangaben: | Mark O. Wielpütz and Marcus A. Mall |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1906017077 | ||
| 003 | DE-627 | ||
| 005 | 20241205181642.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 241018s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1183/13993003.00234-2024 |2 doi | |
| 035 | |a (DE-627)1906017077 | ||
| 035 | |a (DE-599)KXP1906017077 | ||
| 035 | |a (OCoLC)1475315993 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wielpütz, Mark Oliver |d 1982- |e VerfasserIn |0 (DE-588)139999752 |0 (DE-627)614754682 |0 (DE-576)314127046 |4 aut | |
| 245 | 1 | 0 | |a Therapeutic improvement of CFTR function and reversibility of bronchiectasis in cystic fibrosis |c Mark O. Wielpütz and Marcus A. Mall |
| 264 | 1 | |c 14 Feb 2024 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 18.10.2024 | ||
| 520 | |a The study by Cazier and co-workers promotes current efforts to diagnose and treat CF lung disease as early as possible in order to prevent structural lung damage, and to target initially reversible changes before persistent airway damage is established | ||
| 700 | 1 | |a Mall, Marcus A. |d 1975- |e VerfasserIn |0 (DE-588)115507795 |0 (DE-627)691370532 |0 (DE-576)28992152X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The European respiratory journal |d Lausanne : ERS, 1988 |g 63(2024), 3, Artikel-ID 2400234, Seite 2400234-1-2400234-6 |h Online-Ressource |w (DE-627)306646803 |w (DE-600)1499101-9 |w (DE-576)091142504 |x 1399-3003 |7 nnas |a Therapeutic improvement of CFTR function and reversibility of bronchiectasis in cystic fibrosis |
| 773 | 1 | 8 | |g volume:63 |g year:2024 |g number:3 |g elocationid:2400234 |g pages:2400234-1-2400234-6 |g extent:6 |a Therapeutic improvement of CFTR function and reversibility of bronchiectasis in cystic fibrosis |
| 856 | 4 | 0 | |u https://doi.org/10.1183/13993003.00234-2024 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://erj.ersjournals.com/content/63/3/2400234 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20241018 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 115507795 |a Mall, Marcus A. |m 115507795:Mall, Marcus A. |p 2 |y j | ||
| 998 | |g 139999752 |a Wielpütz, Mark Oliver |m 139999752:Wielpütz, Mark Oliver |d 910000 |d 911400 |d 50000 |e 910000PW139999752 |e 911400PW139999752 |e 50000PW139999752 |k 0/910000/ |k 1/910000/911400/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1906017077 |e 4598877065 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"role":"aut","given":"Mark Oliver","display":"Wielpütz, Mark Oliver","family":"Wielpütz"},{"family":"Mall","display":"Mall, Marcus A.","role":"aut","given":"Marcus A."}],"name":{"displayForm":["Mark O. Wielpütz and Marcus A. Mall"]},"physDesc":[{"extent":"6 S."}],"recId":"1906017077","relHost":[{"part":{"issue":"3","text":"63(2024), 3, Artikel-ID 2400234, Seite 2400234-1-2400234-6","year":"2024","pages":"2400234-1-2400234-6","volume":"63","extent":"6"},"titleAlt":[{"title":"official journal of the European Society for Clinical Respiratory Physiology : ERJ"},{"title":"ERJ"}],"language":["eng"],"corporate":[{"display":"European Respiratory Society","role":"isb"}],"id":{"issn":["1399-3003"],"zdb":["1499101-9"],"eki":["306646803"]},"recId":"306646803","name":{"displayForm":["European Respiratory Society"]},"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Therapeutic improvement of CFTR function and reversibility of bronchiectasis in cystic fibrosisThe European respiratory journal","origin":[{"dateIssuedDisp":"1988-","dateIssuedKey":"1988","publisher":"ERS ; Munksgaard","publisherPlace":"Lausanne ; Copenhagen"}],"note":["Gesehen am 25.04.2025","Fortsetzung der Druck-Ausgabe"],"pubHistory":["1.1988 -"],"title":[{"title":"The European respiratory journal","subtitle":"flagship scientific journal of ERS","title_sort":"European respiratory journal"}]}],"id":{"eki":["1906017077"],"doi":["10.1183/13993003.00234-2024"]},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"14 Feb 2024"}],"note":["Gesehen am 18.10.2024"],"title":[{"title":"Therapeutic improvement of CFTR function and reversibility of bronchiectasis in cystic fibrosis","title_sort":"Therapeutic improvement of CFTR function and reversibility of bronchiectasis in cystic fibrosis"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a WIELPUETZMTHERAPEUTI1420 | ||